Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer

被引：0
|
作者：
Yoshitaka Saito
Yoh Takekuma
Yoshito Komatsu
Mitsuru Sugawara
机构：
[1] Hokkaido University Hospital,Department of Pharmacy
[2] Hokkaido University Hospital,Cancer Center
[3] Hokkaido University,Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences
来源：
International Journal of Clinical Oncology | 2023年 / 28卷
关键词：
Regorafenib; Severe hypertension; Metastatic colorectal cancer (mCRC); Vascular endothelial growth factor (VEGF); Progression-free survival; Multikinase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1183 / 1190
页数：7
相关论文
共 50 条
  • [1] Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer
    Saito, Yoshitaka
    Takekuma, Yoh
    Komatsu, Yoshito
    Sugawara, Mitsuru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (09) : 1183 - 1190
  • [2] Panitumumab significantly improves progression-free survival in patients with metastatic colorectal cancer
    Van Cutsem, E.
    Peeters, M.
    Siena, S.
    Humblet, Y.
    Hendisz, A.
    Neyns, B.
    Canon, J.
    Van Laethem, J.
    Maurel, J.
    Richardson, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 27 - 27
  • [3] Panitumumab improves progression-free survival in metastatic colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (14): : 1800 - 1801
  • [4] Cetuximab significantly improves progression-free survival and disease control in metastatic colorectal cancer patients
    不详
    ONCOLOGY-NEW YORK, 2007, 21 (06): : 739 - 739
  • [5] Progression-free survival with regorafenib in gastric cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2016, 17 (08): : E323 - E323
  • [6] Oxaliplatin improves progression-free survival in patients with colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (01): : 83 - 83
  • [7] CORRECT trial: regorafenib significantly increases overall and progression-free survival
    不详
    COLORECTAL CANCER, 2012, 1 (04) : 283 - 283
  • [8] Osimertinib improves the significantly and clinically relevant progression-free Survival in Lung Cancer
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (10) : 638 - 638
  • [9] Progression-free survival in metastatic, BRAF-mutated colorectal cancer
    Morris, Van Karlyle
    Overman, Michael J.
    Maru, Dipen M.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [10] Metastatic colorectal cancer patients who achieved long progression-free survival by regorafenib or TAS-102 therapy
    Kito, Yosuke
    Hamauchi, Satoshi
    Yamazaki, Kentaro
    Komori, Azusa
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Mori, Keita
    Muro, Kei
    Yasui, Hirofumi
    ANNALS OF ONCOLOGY, 2016, 27
12345